Randomized Clinical Trials of Inhaled Antibiotics in Bronchiectasis: Cause for Optimism?

Chest. 2023 Jan;163(1):3-5. doi: 10.1016/j.chest.2022.09.003.

Authors

Conroy Wong¹, Miguel Angel Martinez-Garcia²

Affiliations

¹ Department of Respiratory Medicine, Middlemore Hospital, Auckland, NZ; Department of Medicine, University of Auckland, Auckland, NZ.
² Respiratory Department, La Fe University and Politechnic Hospital, Valencia, Spain; CIBERES de enfermedades respiratorias, Instituto de salud Carlos III, Madrid, Spain. Electronic address: mianmartinezgarcia@gmail.com.

PMID: 36628672
DOI: 10.1016/j.chest.2022.09.003

No abstract available

Publication types

Editorial
Comment

MeSH terms

Administration, Inhalation
Anti-Bacterial Agents / therapeutic use
Bronchiectasis* / drug therapy
Humans
Pseudomonas Infections* / drug therapy
Randomized Controlled Trials as Topic

Substances

Anti-Bacterial Agents